BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7528489)

  • 1. [CMDBS, functional analogs of sulfate heparanes, used as osseous cicatrizing agents].
    Blanquaert F; Barritault D; Saffar JL; Josefonvicz J; Caruelle JP
    Ann Endocrinol (Paris); 1994; 55(2):121-3. PubMed ID: 7528489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan-like molecules induce the repair of skull defects.
    Blanquaert F; Saffar JL; Colombier ML; Carpentier G; Barritault D; Caruelle JP
    Bone; 1995 Dec; 17(6):499-506. PubMed ID: 8835301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches to tissue regeneration and repair.
    Meddahi A; Blanquaert F; Saffar JL; Colombier ML; Caruelle JP; Josefonvicz J; Barritault D
    Pathol Res Pract; 1994 Oct; 190(9-10):923-8. PubMed ID: 7534914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMDBS, functional analogue of heparin sulfate as a new class of corneal ulcer healing agents.
    Fredj-Reygrobellet D; Hristova DL; Ettaiche M; Meddahi A; Jozefonwicz J; Barritault D
    Ophthalmic Res; 1994; 26(6):325-31. PubMed ID: 7536320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New concepts in tissue repair: skin as an example.
    Meddahi A; Caruelle JP; Gold L; Rosso Y; Barritault D
    Diabetes Metab; 1996 Jul; 22(4):274-8. PubMed ID: 8767175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGFs and their receptors, in vitro and in vivo studies: new FGF receptor in the brain, FGF-1 in muscle, and the use of functional analogues of low-affinity heparin-binding growth factor receptors in tissue repair.
    Soulet L; Chevet E; Lemaitre G; Blanquaert F; Meddahi A; Barritault D
    Mol Reprod Dev; 1994 Sep; 39(1):49-54; discussion 54-5. PubMed ID: 7528027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGTA modulates the healing pattern of a defect in a monolayer of osteoblastic cells by acting on both proliferation and migration.
    Blanquaert F; Carpentier G; Morvan F; Caruelle JP; Barritault D; Tardieu M
    J Biomed Mater Res A; 2003 Mar; 64(3):525-32. PubMed ID: 12579567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxymethyl benzylamide sulfonate dextrans (CMDBS), a family of biospecific polymers endowed with numerous biological properties: a review.
    Logeart-Avramoglou D; Jozefonvicz J
    J Biomed Mater Res; 1999; 48(4):578-90. PubMed ID: 10421704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGTA11, a new healing agent, triggers developmental events during healing of craniotomy defects in adult rats.
    Lafont J; Baroukh B; Berdal A; Colombier ML; Barritault D; Caruelle JP; Saffar JL
    Growth Factors; 1998; 16(1):23-38. PubMed ID: 9777368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-like synthetic polymers, named RGTAs, mimic biological effects of heparin in vitro.
    Rouet V; Meddahi-Pellé A; Miao HQ; Vlodavsky I; Caruelle JP; Barritault D
    J Biomed Mater Res A; 2006 Sep; 78(4):792-7. PubMed ID: 16741978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Heparan Sulfate Device for the Regeneration of Osteochondral Defects.
    Lee JH; Luo X; Ren X; Tan TC; Smith RAA; Swaminathan K; Sekar S; Bhakoo K; Nurcombe V; Hui JH; Cool SM
    Tissue Eng Part A; 2019 Mar; 25(5-6):352-363. PubMed ID: 30351222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic study of early regenerative effects of RGTA11, a heparan sulfate mimetic, in rat craniotomy defects.
    Lafont J; Blanquaert F; Colombier ML; Barritault D; Carueelle JP; Saffar JL
    Calcif Tissue Int; 2004 Dec; 75(6):517-25. PubMed ID: 15654496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling.
    Hsia E; Richardson TP; Nugent MA
    J Cell Biochem; 2003 Apr; 88(6):1214-25. PubMed ID: 12647303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis.
    Jackson RA; Nurcombe V; Cool SM
    Gene; 2006 Sep; 379():79-91. PubMed ID: 16797878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of dextran derivatives in vitro on the growth characteristics of premalignant and malignant human mammary epithelial cell lines.
    Bagheri-Yarmand R; Morere JF; Letourneur D; Jozefonvicz J; Israel L; Crepin M
    Anticancer Res; 1992; 12(5):1641-6. PubMed ID: 1280032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF protection and inhibition of human neutrophil elastase by carboxymethyl benzylamide sulfonate dextran derivatives.
    Meddahi A; Lemdjabar H; Caruelle JP; Barritault D; Hornebeck W
    Int J Biol Macromol; 1996 Feb; 18(1-2):141-5. PubMed ID: 8852763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix heparan sulfate proteoglycans modulate the mitogenic capacity of acidic fibroblast growth factor.
    Gordon PB; Choi HU; Conn G; Ahmed A; Ehrmann B; Rosenberg L; Hatcher VB
    J Cell Physiol; 1989 Sep; 140(3):584-92. PubMed ID: 2528552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single low dose of RGTA, a new healing agent, hastens wound maturation and enhances bone deposition in rat craniotomy defects.
    Colombier ML; Lafont J; Blanquaert F; Caruelle JP; Barritault D; Saffar JL
    Cells Tissues Organs; 1999; 164(3):131-40. PubMed ID: 10352345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGTA
    Barritault D; Gilbert-Sirieix M; Rice KL; Siñeriz F; Papy-Garcia D; Baudouin C; Desgranges P; Zakine G; Saffar JL; van Neck J
    Glycoconj J; 2017 Jun; 34(3):325-338. PubMed ID: 27924424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cranial bone healing with a heparin-like dextran derivative.
    Albo D; Long C; Jhala N; Atkinson B; Granick MS; Wang T; Meddahi A; Barritault D; Solomon MP
    J Craniofac Surg; 1996 Jan; 7(1):19-22. PubMed ID: 9086897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.